Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase II trial designed to determine the efficacy and safety of perifosine in
patients with leukemia who develop progressive disease or recurrence while receiving therapy.